CB2 — Drug Target
All drugs that target CB2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (2)
- APD356 · Eisai Inc. · CB2 receptor agonist · Neurology
APD356 is a selective agonist of the cannabinoid receptor type 2 (CB2). - CT327 ointment · Creabilis SA · CB2 receptor agonist · Pain management
CT327 ointment is a topical treatment that targets the cannabinoid receptor type 2 (CB2) to reduce inflammation and pain.